Loading chat...
OH SB231
Bill
Status
Introduced
11/4/2019
Primary Sponsor
Hearcel Craig
Click for details
AI Summary
- Attorney General shall investigate prescription drug pricing containing insulin to ensure adequate consumer protections and determine if additional protections are needed
- Attorney General may issue civil investigative demands to state departments, health plan issuers, pharmacy benefit managers, drug manufacturers, and pharmacies for business practices, pricing data, and other relevant information
- Information furnished to the Attorney General is confidential and not subject to public records disclosure
- Attorney General must submit a report no later than 18 months after the effective date to the Governor, Superintendent of Insurance, and relevant legislative committees detailing current insulin pricing practices, variables contributing to pricing, and recommendations for controlling overpricing and preventing deceptive sales practices
Legislative Description
Investigate insulin pricing
Health and Human Services : Health Care
Last Action
Refer to Committee: Finance Subcommittee on Health and Medicaid
11/13/2019
Committee Referrals
Finance - Health and Medicaid Subcommittee11/13/2019
Full Bill Text
No bill text available